CannBioRx Life Sciences Corp

Prices are adjusted according to historical splits.

CannBioRx Life Sciences Corp Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$250.78 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

CannBioRx Life Sciences Corp had its IPO on 2017-06-27 under the ticker symbol ATNFW.

The company operates in the sector and industry. CannBioRx Life Sciences Corp has a staff strength of 0 employees.

Stock update

Shares of CannBioRx Life Sciences Corp opened at $0.03 at the start of the last trading session i.e. 2023-03-21.

The stocks traded within a range of $0.02 - $0.03, and closed at $0.03.

This is a -10.88% slip from the previous day's closing price.

A total volume of 108,495 shares were traded at the close of the day’s session.

In the last one week, shares of CannBioRx Life Sciences Corp have slipped by -15.48%.

CannBioRx Life Sciences Corp's Key Ratios

CannBioRx Life Sciences Corp has a market cap of $250.78 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months CannBioRx Life Sciences Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $-20990946. The EBITDA ratio measures CannBioRx Life Sciences Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, CannBioRx Life Sciences Corp’s operating margin was 0% while its return on assets stood at -42.24% with a return of equity of -3754.4%.

In Q3, CannBioRx Life Sciences Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

CannBioRx Life Sciences Corp’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into CannBioRx Life Sciences Corp’s profitability.

CannBioRx Life Sciences Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

CannBioRx Life Sciences Corp stock pays annual dividends of $ per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$34.34 million
Total Liabilities
$4.72 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

CannBioRx Life Sciences Corp ended 2023 with $34.34 million in total assets and $0 in total liabilities. Its intangible assets were valued at $34.34 million while shareholder equity stood at $26.08 million.

CannBioRx Life Sciences Corp ended 2023 with $3.50 million in deferred long-term liabilities, $4.72 million in other current liabilities, 3924.00 in common stock, $-85666267.00 in retained earnings and $13.97 million in goodwill. Its cash balance stood at $3.59 million and cash and short-term investments were $3.59 million. The company’s total short-term debt was $406,450 while long-term debt stood at $31522.00.

CannBioRx Life Sciences Corp’s total current assets stands at $6.51 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $2.51 million compared to accounts payable of $1.02 million and inventory worth $0.

In 2023, CannBioRx Life Sciences Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, CannBioRx Life Sciences Corp paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

CannBioRx Life Sciences Corp stock is currently trading at $0.03 per share. It touched a 52-week high of $0.6298 and a 52-week low of $0.6298. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.04 and 200-day moving average was $0.09 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About CannBioRx Life Sciences Corp

The stock symbol (also called stock or share ticker) of CannBioRx Life Sciences Corp is ATNFW

The IPO of CannBioRx Life Sciences Corp took place on 2017-06-27

Most Active

Last Price
Tesla Inc (TSLA)

Top Gainers

Last Price

Top Losers

Last Price
Imara Inc (IMRA)


180 Life Sciences Corp., a clinical-stage biotechnology company, focuses on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis, and pain. Its primary platform is a novel program to treat fibrosis and inflammation using anti-TNF, with its lead program in phase 2b/3 clinical trial. The company is headquatered in Menlo Park, California.


830 Menlo Avenue, Menlo Park, CA, United States, 94025